Molzyme Wins CE-IVD Marking for Pathogen Test

Jan

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb

Featured Webinar

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Main menu

Molzyme Wins CE-IVD Marking for Pathogen Test

To read the full story....

Breaking News

New Breast Cancer Pathology Testing Guideline Published by CAP

BD Preliminary Fiscal Q1 Revenues Up 35 Percent on Continued Bard Boost

Abbott Inks Blood Screening Deal With Japanese Red Cross

Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug

Theradiag Gets CE Mark for Cosentyx Response Kit

Roche, PhoenixMD Collaborating on CDx for Triple-Negative Breast Cancer Drug

Featured White Papers

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

What's Popular?

Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug

Minimal Residual Disease Sequencing Poised to Grow Following Lag in Adoption

Predigen Diagnostics Developing Gene Expression Platform to Differentiate Bacterial from Viral Infections

BD Preliminary Fiscal Q1 Revenues Up 35 Percent on Continued Bard Boost

BioFluidica Applying Liquid Biopsy to Detect Leukemia While Reducing Biopsies

Sponsorships